191 related articles for article (PubMed ID: 30805126)
1. Extensive osteonecrosis of the maxilla caused by bisphosphonates: Report of a rare case.
Santos M; Silveira K; Souza N; Costa D; Inaoka S
J Clin Exp Dent; 2019 Feb; 11(2):e203-e207. PubMed ID: 30805126
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report.
Otto S; Sotlar K; Ehrenfeld M; Pautke C
J Med Case Rep; 2011 Sep; 5():477. PubMed ID: 21943059
[TBL] [Abstract][Full Text] [Related]
4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
5. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonate related osteonecrosis of the jaws: a case report and review of the literature].
Ye WC; Li Y; Zhang B
Shanghai Kou Qiang Yi Xue; 2012 Jun; 21(3):354-8. PubMed ID: 22885505
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.
Haidar A; Jønler M; Folkmar TB; Lund L
Scand J Urol Nephrol; 2009; 43(6):442-4. PubMed ID: 19903091
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw due to bisphosphonates.
Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
[TBL] [Abstract][Full Text] [Related]
12. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports.
Sarathy AP; Bourgeois SL; Goodell GG
J Endod; 2005 Oct; 31(10):759-63. PubMed ID: 16186759
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonates and osteonecrosis of the jaw].
Schirmer I; Peters H; Reichart PA; Dürkop H
Mund Kiefer Gesichtschir; 2005 Jul; 9(4):239-45. PubMed ID: 15918066
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
16. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
Lee J
J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
18. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
Sánchez A; Blanco R
Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaw: an overview.
Ruggiero SL
Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
